Mink Therapeutics Inc
NASDAQ:INKT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Mink Therapeutics Inc
NASDAQ:INKT
|
US |
|
MatsukiyoCocokara & Co
TSE:3088
|
JP |
|
Montrose Environmental Group Inc
NYSE:MEG
|
US |
|
Genco Shipping & Trading Ltd
NYSE:GNK
|
US |
|
Tempur Sealy International Inc
NYSE:TPX
|
US |
|
CONSOL Energy Inc
NYSE:CEIX
|
US |
|
Mckesson Corp
NYSE:MCK
|
US |
|
PLC SpA
MIL:PLC
|
IT |
|
VICI Properties Inc
NYSE:VICI
|
US |
|
Quest Diagnostics Inc
NYSE:DGX
|
US |
|
Yuanta Financial Holding Co Ltd
TWSE:2885
|
TW |
|
Sanlorenzo SpA
MIL:SL
|
IT |
|
Commercial Metals Co
NYSE:CMC
|
US |
|
SMCP SA
PAR:SMCP
|
FR |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Fastenal Co
NASDAQ:FAST
|
US |
|
Shore Bancshares Inc
NASDAQ:SHBI
|
US |
|
Bark Inc
NYSE:BARK
|
US |
|
CBAK Energy Technology Inc
NASDAQ:CBAT
|
CN |
|
FTI Consulting Inc
NYSE:FCN
|
US |
|
ON Semiconductor Corp
NASDAQ:ON
|
US |
|
Piedmont Office Realty Trust Inc
NYSE:PDM
|
US |
|
Chimera Investment Corp
NYSE:CIM
|
US |
|
Cohort PLC
LSE:CHRT
|
UK |
Bankruptcy Probability
Mink Therapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Mink Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Mink Therapeutics Inc
NASDAQ:INKT
|
49.1m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
376.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
181.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
166.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
110.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
67.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
43B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
39.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Mink Therapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Mink Therapeutics Inc has total debt of 5.2m USD. This includes both short-term (5.2m USD) and long-term (0 USD) debt.
You can find a full breakdown on its Balance Sheet.
